Purpose: To compare conventional 30° spectral domain optical coherence tomography (SD-OCT) with 55° wide-field SD-OCT for the assessment of diabetic macular edema (DME). Methods: This study included 50 DME patients. Both 55° and 30° SD-OCT was conducted. Two readers evaluated scans according to a standardized grading protocol. Intergrader agreement as well as agreement between 30° and 55° SD-OCT were assessed. Results: Intergrader agreement (κ) was strong and ranged from 0.79 to 1.0. Perfect interdevice agreement (κ = 1.0) was found for the detection of intra- and subretinal fluid. Excellent agreement (κ ≥ 0.9) was found for the presence of epiretinal membrane (κ = 0.92) and cotton-wool spots (κ = 0.92). A strong agreement was found for the presence of hard exudates (κ = 0.89) and microaneurysms (κ = 0.81). A moderate correlation was found for ellipsoid zone integrity (κ = 0.69) and configuration of the vitreomacular interface (VMI) (κ = 0.69). A weak agreement was found for retinal pigment epithelium atrophy (κ = 0.51) and external limiting membrane integrity (κ = 0.35). Conclusion: Wide-field OCT imaging may be beneficial for evaluating DME, particularly for assessing the VMI and the integrity of hyperreflective bands.

Keywords:
Wide-field imaging, Diabetic macular edema, Wide-field spectral domain optical coherence tomography, Microaneurysms, Vitreoretinal interface, Macular edema, Subretinal fluid, Intraretinal fluid, Hard exudates
1.
Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA, et al: Optical coherence tomography. Science 1991;254:1178-1181.
2.
Zysk AM, Nguyen FT, Oldenburg AL, Marks DL, Boppart SA: Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt 2007;12:051403.
3.
Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, Schuman JS, Swanson EA, Fujimoto JG: Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998;105:360-370.
4.
Browning DJ, McOwen MD, Bowen RM Jr, O'Marah TL: Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 2004;111:712-715.
5.
Kolb JP, Klein T, Kufner CL, Wieser W, Neubauer AS, Huber R: Ultra-widefield retinal MHz-OCT imaging with up to 100 degrees viewing angle. Biomed Opt Express 2015;6:1534-1552.
6.
Carrai P, Pichi F, Bonsignore F, Ciardella AP, Nucci P: Wide-field spectral domain-optical coherence tomography in central serous chorioretinopathy. Int Ophthalmol 2015;35:167-171.
7.
Uji A, Yoshimura N: Application of extended field imaging to optical coherence tomography. Ophthalmology 2015;122:1272-1274.
8.
Pichi F, Carrai P, Bonsignore F, Villani E, Ciardella AP, Nucci P: Wide-field spectral domain optical coherence tomography. Retina 2015;35:2584-2592.
9.
Gregori NZ, Lam BL, Gregori G, Ranganathan S, Stone EM, Morante A, Abukhalil F, Aroucha PR: Wide-field spectral-domain optical coherence tomography in patients and carriers of X-linked retinoschisis. Ophthalmology 2013;120:169-174.
10.
Mori K, Kanno J, Gehlbach PL: Retinochoroidal morphology described by wide-field montage imaging of spectral domain optical coherence tomography. Retina 2016;36:375-384.
11.
McNabb RP, Grewal DS, Mehta R, Schuman SG, Izatt JA, Mahmoud TH, Jaffe GJ, Mruthyunjaya P, Kuo AN: Wide field of view swept-source optical coherence tomography for peripheral retinal disease. Br J Ophthalmol 2016;100:1377-1382.
12.
Balasubramanian M, Bowd C, Vizzeri G, Weinreb RN, Zangwill LM: Effect of image quality on tissue thickness measurements obtained with spectral domain-optical coherence tomography. Opt Express 2009;17:4019-4036.
13.
Munk MR, Kiss CG, Huf W, Montuoro A, Sulzbacher F, Kroh M, Larsen M, Schmidt-Erfurth U: Visual acuity and microperimetric mapping of lesion area in eyes with inflammatory cystoid macular oedema. Acta Ophthalmol 2014;92:332-338.
14.
Munk MR, Sacu S, Huf W, Sulzbacher F, Mittermuller TJ, Eibenberger K, Rezar S, Bolz M, Kiss CG, Simader C, Schmidt-Erfurth U: Differential diagnosis of macular edema of different pathophysiologic origins by spectral domain optical coherence tomography. Retina 2014;34:2218-2232.
15.
Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P: The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 2013;120:2611-2619.
16.
Munk MR, Jampol LM, Simader C, Huf W, Mittermuller TJ, Jaffe GJ, Schmidt-Erfurth U: Differentiation of diabetic macular edema from pseudophakic cystoid macular edema by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2015;56:6724-6733.
17.
Munk MR, Ram R, Rademaker A, Liu D, Setlur V, Chau F, Schmidt-Erfurth U, Goldstein DA: Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema. Acta Ophthalmol 2015;93:e561-e567.
18.
McHugh ML: Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012;22:276-282.
19.
Mori K, Kanno J, Gehlbach PL, Yoneya S: Montage images of spectral-domain optical coherence tomography in eyes with idiopathic macular holes. Ophthalmology 2012;119:2600-2608.
20.
Rao P, Robinson J, Yonekawa Y, Thomas BJ, Drenser KA, Trese MT, Capone A Jr: Wide-field imaging of nonexudative and exudative congenital X-linked retinoschisis. Retina 2016;36:1093-1100.
21.
Sadiq MA, Soliman MK, Sarwar S, Agarwal A, Hanout M, Demirel S, Rentiya ZS, Khan W, Do DV, Nguyen QD, Sepah YJ: Effect of vitreomacular adhesion on treatment outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study. Ophthalmology 2016;123:324-329.
22.
Ciulla TA, Ying GS, Maguire MG, Martin DF, Jaffe GJ, Grunwald JE, Daniel E, Toth CA: Influence of the vitreomacular interface on treatment outcomes in the comparison of age-related macular degeneration treatments trials. Ophthalmology 2015;122:1203-1211.
23.
Barteselli G, Bartsch DU, Viola F, Mojana F, Pellegrini M, Hartmann KI, Benatti E, Leicht S, Ratiglia R, Staurenghi G, Weinreb RN, Freeman WR: Accuracy of the Heidelberg Spectralis in the alignment between near-infrared image and tomographic scan in a model eye: a multicenter study. Am J Ophthalmol 2013;156:588-592.
24.
Diabetic Retinopathy Clinical Research Network, Elman MJ, Qin H, Aiello LP, Beck RW, Bressler NM, Ferris FL 3rd, Glassman AR, Maturi RK, Melia M: Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology 2012;119:2312-2318.
25.
American Academy of Ophthalmology: Preferred Practice Patterns. Diabetic Retinopathy PPP-2014. http://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp-2014#top (accessed February 17, 2016).
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.